Výsledky vyhledávání

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

POS1366 RITUXIMAB IN IgG4-RD: AN OPEN-LABEL NON-RANDOMIZED OBSERVATIONAL STUDY

Autor: J. Vikse, Ø. Midtvedt, Ø. Molberg, B. T. Svanes Fevang, Ø. Palm, T. Garen, K. B. Norheim, G. Bakland, M. Wallenius, A. M. Hoffmann-Vold

Publikováno v: Annals of the Rheumatic Diseases. 81:1022-1023

BackgroundIgG4-related disease (IgG4-RD) is a rare, heterogenous and potentially severe disease. An open-label trial demonstrated efficacy of rituximab (RTX) in IgG4-RD [1]. Recently, four distinct phenotypes of IgG4-RD were identified [2]. There is

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::45ade5fbff30a933d5d14d5acfd13814
https://doi.org/10.1136/annrheumdis-2022-eular.4340

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

AB0580 BEHÇET’S DISEASE IN OSLO NORWAY IN PERIOD 1999 – 2021

Autor: J. L. Lorentsen, K. Lerang, T. Garen, Ø. Palm

Publikováno v: Annals of the Rheumatic Diseases. 81:1415.1-1415

BackgroundBechet’s disease (BD) is a multisystemic, inflammatory disease, characterized by variety of clinical manifestations, including mucocutaneous, ocular, vascular, neurological (CNS) and gastrointestinal (GI) involvements. The disease can be

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c6778a69830482595901cfd0486ee785
https://doi.org/10.1136/annrheumdis-2022-eular.635

Zobrazit plný text záznamu

POS1575-PARE WORKING AND HEALTH STATUS IN NORWEGIAN PATIENTS WITH TAKAYASU ARTERITIS

Autor: T. Garen, A. Tollisen, H. Andersson, B. Gudbrandsson, Ø. Palm

Publikováno v: Annals of the Rheumatic Diseases. 81:1133.1-1134

BackgroundTakayasu arteritis (TAK) is a rare vasculitis of large vessels, mainly in young women, with a point prevalence of 25.6/106 in a Norwegian population. TAK is most prevalently limited to the aortic arch and its branches (Type 1) among North E

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::373f1fbabb95b14855d730af10234c0a
https://doi.org/10.1136/annrheumdis-2022-eular.4289

Zobrazit plný text záznamu

POS0870 PATIENTS WITH SYSTEMIC SCLEROSIS HAVE IMPAIRED FORCED VITAL CAPACITY, EVEN IN THE ABSENCE OF INTERSTITIAL LUNG DISEASE

Autor: H. Fretheim, I. Barua, Ø. Midtvedt, T. Garen, P. P. Diep, M. Durheim, C. Brunborg, A. M. Hoffmann-Vold

Publikováno v: Annals of the Rheumatic Diseases. 81:729.2-730

BackgroundSpirometry, in particular forced vital capacity (FVC), is a widely implemented tool in the initial diagnostic workup and monitoring of systemic sclerosis-related interstitial lung disease (SSc-ILD). In addition to ILD, several other extra-p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::066ac659d75f5fc399a20606338559af
https://doi.org/10.1136/annrheumdis-2022-eular.1932

Zobrazit plný text záznamu

POS0065 INTERSTITIAL LUNG DISEASE ASSOCIATED WITH PRIMARY SJÖGREN’S SYNDROME IS FREQUENTLY PROGRESSIVE

Autor: A. M. Hoffmann-Vold, H. Fretheim, P. P. Diep, K. Lerang, H. Andersson, Ø. Midtvedt, T. Garen, M. Durheim, T. M. Aaløkken, Ø. Palm, Ø. Molberg

Publikováno v: Annals of the Rheumatic Diseases. 81:249.3-249

BackgroundInterstitial lung disease (ILD) in primary Sjögren’s syndrome (pSS) has been reported to be present in 10-15% of patients, but pSS-ILD behavior over time is not well characterized.ObjectivesAssess the pattern of ILD in pSS, its disease b

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9dcb047ff40b1026bcb93364d1dd386a
https://doi.org/10.1136/annrheumdis-2022-eular.4062

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání